Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...
Pharmabiz

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA: Basel Wednesday, November 26, 2025, 09:00 Hrs ...

Novartis receives FDA approval for Itvisma(R), the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...
Technology Networks

Lipid-Based Systems’ Potential To Transform CAR T Therapy for Solid Tumors

In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the ...
The American Journal of Managed Care

Reactivating CCNA2 Gene Enables Adult Heart Cells to Regenerate

Reintroduction of the Cyclin A2 gene enables adult human cardiomyocytes to divide, producing functional daughter cells and promoting heart repair. The therapy uses a replication-deficient adenoviral ...
EurekAlert!

Ancient ‘animal GPS system’ identified in magnetic fossils

The earliest evidence of an internal ‘GPS’ system in an animal has been identified by researchers, which could help explain ...

Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Server Security Scanner Vulnerability Affects Up To 56M Sites

Unpatched versions of Imunify360 AV expose hosting platforms that serve up to 56 million websites to possible full server ...

What does 2026 hold for IT governance?

In 2026, businesses should be shifting their IT governance focus to tackle 'non-human' identity risks and clamp down on ...
Opinion
The Maravi PostOpinion

The Role of Government in Fostering Entrepreneurship

Failure by municipal and national govern­ments in any given country to provide adequately for the needs of both small, medium and large business enterprises can significantly reduce the po­tential of ...

Novartis Pharma AG: Novartis receives FDA approval for Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular ...

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...

4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Good morning, and welcome to the Jefferies 2025 Healthcare Conference. It's my pleasure now to introduce David Kirn, CEO; and Chris Simms, Chief Commercial Officer of 4D Molecular Therapeutics. All ...